Coexpression cluster:C233: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0007023!7.94e-36!115;UBERON:0001049!2.94e-12!57;UBERON:0005068!2.94e-12!57;UBERON:0006241!2.94e-12!57;UBERON:0007135!2.94e-12!57;UBERON:0000073!6.10e-11!94;UBERON:0001016!6.10e-11!94;UBERON:0001017!6.84e-11!82;UBERON:0005743!2.05e-10!86;UBERON:0002616!6.15e-10!59;UBERON:0003080!1.89e-09!42;UBERON:0000062!3.90e-09!511;UBERON:0003075!4.15e-09!86;UBERON:0007284!4.15e-09!86;UBERON:0002780!6.43e-09!41;UBERON:0001890!6.43e-09!41;UBERON:0006240!6.43e-09!41;UBERON:0000955!7.58e-09!69;UBERON:0006238!7.58e-09!69;UBERON:0005156!8.63e-09!59;UBERON:0000990!8.63e-09!59;UBERON:0002346!1.66e-08!90;UBERON:0000468!7.30e-08!659;UBERON:0003133!1.41e-07!48;UBERON:0000475!1.65e-07!365;UBERON:0002020!5.98e-07!34;UBERON:0003528!5.98e-07!34;UBERON:0000153!7.61e-07!129;UBERON:0007811!7.61e-07!129;UBERON:0004111!9.17e-07!241;UBERON:0001893!9.26e-07!34 | |ontology_enrichment_uberon=UBERON:0007023!7.94e-36!115;UBERON:0001049!2.94e-12!57;UBERON:0005068!2.94e-12!57;UBERON:0006241!2.94e-12!57;UBERON:0007135!2.94e-12!57;UBERON:0000073!6.10e-11!94;UBERON:0001016!6.10e-11!94;UBERON:0001017!6.84e-11!82;UBERON:0005743!2.05e-10!86;UBERON:0002616!6.15e-10!59;UBERON:0003080!1.89e-09!42;UBERON:0000062!3.90e-09!511;UBERON:0003075!4.15e-09!86;UBERON:0007284!4.15e-09!86;UBERON:0002780!6.43e-09!41;UBERON:0001890!6.43e-09!41;UBERON:0006240!6.43e-09!41;UBERON:0000955!7.58e-09!69;UBERON:0006238!7.58e-09!69;UBERON:0005156!8.63e-09!59;UBERON:0000990!8.63e-09!59;UBERON:0002346!1.66e-08!90;UBERON:0000468!7.30e-08!659;UBERON:0003133!1.41e-07!48;UBERON:0000475!1.65e-07!365;UBERON:0002020!5.98e-07!34;UBERON:0003528!5.98e-07!34;UBERON:0000153!7.61e-07!129;UBERON:0007811!7.61e-07!129;UBERON:0004111!9.17e-07!241;UBERON:0001893!9.26e-07!34 | ||
|pathway_enrichment=6.17526981842456e-05;0.0195447289753137;2;38;Nuclear Receptors (Wikipathways):WP170!4.08931644966022e-05;0.0195447289753137;2;31;Ovarian Infertility Genes (Wikipathways):WP34 | |||
}} | }} |
Revision as of 14:58, 13 July 2012
Full id: C233_uterus_cervix_ovary_epididymis_colon_rectum_MCF7
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
6.17526981842456e-05 | 0.0195447289753137 | 2 | 38 | Nuclear Receptors (Wikipathways):WP170 |
4.08931644966022e-05 | 0.0195447289753137 | 2 | 31 | Ovarian Infertility Genes (Wikipathways):WP34 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0047485 | protein N-terminus binding | 0.00862299819090196 |
GO:0005496 | steroid binding | 0.00862299819090196 |
GO:0042977 | tyrosine phosphorylation of JAK2 protein | 0.00862299819090196 |
GO:0042978 | ornithine decarboxylase activator activity | 0.00862299819090196 |
GO:0004925 | prolactin receptor activity | 0.00862299819090196 |
GO:0042976 | activation of JAK protein | 0.00862299819090196 |
GO:0065007 | biological regulation | 0.00862299819090196 |
GO:0003707 | steroid hormone receptor activity | 0.00987327936311198 |
GO:0007308 | oocyte construction | 0.00987327936311198 |
GO:0007309 | oocyte axis determination | 0.00987327936311198 |
GO:0030284 | estrogen receptor activity | 0.00987327936311198 |
GO:0004879 | ligand-dependent nuclear receptor activity | 0.0120644998964412 |
GO:0007171 | transmembrane receptor protein tyrosine kinase activation (dimerization) | 0.0120644998964412 |
GO:0006916 | anti-apoptosis | 0.0120644998964412 |
GO:0043195 | terminal button | 0.0120644998964412 |
GO:0030235 | nitric-oxide synthase regulator activity | 0.0120644998964412 |
GO:0033267 | axon part | 0.0120644998964412 |
GO:0043526 | neuroprotection | 0.0120644998964412 |
GO:0050794 | regulation of cellular process | 0.0127404926994134 |
GO:0043204 | perikaryon | 0.0129247279452068 |
GO:0030315 | T-tubule | 0.0129247279452068 |
GO:0043066 | negative regulation of apoptosis | 0.0136009037720845 |
GO:0048599 | oocyte development | 0.0136009037720845 |
GO:0043069 | negative regulation of programmed cell death | 0.0136009037720845 |
GO:0050789 | regulation of biological process | 0.0140702788789496 |
GO:0009994 | oocyte differentiation | 0.0140702788789496 |
GO:0042979 | ornithine decarboxylase regulator activity | 0.0140702788789496 |
GO:0045885 | positive regulation of survival gene product activity | 0.0155041960416895 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 0.0184473339640376 |
GO:0048523 | negative regulation of cellular process | 0.0184473339640376 |
GO:0030520 | estrogen receptor signaling pathway | 0.0186468984701006 |
GO:0005160 | transforming growth factor beta receptor binding | 0.0186468984701006 |
GO:0048519 | negative regulation of biological process | 0.01872935275268 |
GO:0048468 | cell development | 0.0209223442115531 |
GO:0045104 | intermediate filament cytoskeleton organization and biogenesis | 0.0216905469581283 |
GO:0045103 | intermediate filament-based process | 0.0225916600030853 |
GO:0045884 | regulation of survival gene product activity | 0.0228267795774616 |
GO:0042383 | sarcolemma | 0.0228267795774616 |
GO:0007566 | embryo implantation | 0.023038068441521 |
GO:0048477 | oogenesis | 0.023038068441521 |
GO:0009798 | axis specification | 0.0237954903388163 |
GO:0007281 | germ cell development | 0.0245165410777021 |
GO:0007595 | lactation | 0.0264608312544518 |
GO:0043523 | regulation of neuron apoptosis | 0.0307705672403622 |
GO:0042562 | hormone binding | 0.031286565321858 |
GO:0051402 | neuron apoptosis | 0.0352984815400051 |
GO:0030424 | axon | 0.037782476750978 |
GO:0007292 | female gamete generation | 0.037782476750978 |
GO:0043025 | cell soma | 0.037782476750978 |
GO:0042981 | regulation of apoptosis | 0.037782476750978 |
GO:0043067 | regulation of programmed cell death | 0.037782476750978 |
GO:0008289 | lipid binding | 0.037782476750978 |
GO:0048869 | cellular developmental process | 0.037782476750978 |
GO:0030154 | cell differentiation | 0.037782476750978 |
GO:0007259 | JAK-STAT cascade | 0.038338450462916 |
GO:0045449 | regulation of transcription | 0.0388811799911008 |
GO:0016585 | chromatin remodeling complex | 0.0388811799911008 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0403349002062704 |
GO:0007267 | cell-cell signaling | 0.0406006327953373 |
GO:0044463 | cell projection part | 0.0417295745523015 |
GO:0006350 | transcription | 0.0417295745523015 |
GO:0010468 | regulation of gene expression | 0.0422068599713276 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 0.0428548548408523 |
GO:0030518 | steroid hormone receptor signaling pathway | 0.0430238910265278 |
GO:0031323 | regulation of cellular metabolic process | 0.0440653693060164 |
GO:0030522 | intracellular receptor-mediated signaling pathway | 0.0449711386481836 |
GO:0048609 | reproductive process in a multicellular organism | 0.0483759551790002 |
GO:0032504 | multicellular organism reproduction | 0.0483759551790002 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
adult organism | 7.94e-36 | 115 |
neural tube | 2.94e-12 | 57 |
neural rod | 2.94e-12 | 57 |
future spinal cord | 2.94e-12 | 57 |
neural keel | 2.94e-12 | 57 |
regional part of nervous system | 6.10e-11 | 94 |
nervous system | 6.10e-11 | 94 |
central nervous system | 6.84e-11 | 82 |
regional part of brain | 6.15e-10 | 59 |
anterior neural tube | 1.89e-09 | 42 |
organ | 3.90e-09 | 511 |
neural plate | 4.15e-09 | 86 |
presumptive neural plate | 4.15e-09 | 86 |
regional part of forebrain | 6.43e-09 | 41 |
forebrain | 6.43e-09 | 41 |
future forebrain | 6.43e-09 | 41 |
brain | 7.58e-09 | 69 |
future brain | 7.58e-09 | 69 |
reproductive structure | 8.63e-09 | 59 |
reproductive system | 8.63e-09 | 59 |
neurectoderm | 1.66e-08 | 90 |
multi-cellular organism | 7.30e-08 | 659 |
reproductive organ | 1.41e-07 | 48 |
organism subdivision | 1.65e-07 | 365 |
gray matter | 5.98e-07 | 34 |
brain grey matter | 5.98e-07 | 34 |
anterior region of body | 7.61e-07 | 129 |
craniocervical region | 7.61e-07 | 129 |
anatomical conduit | 9.17e-07 | 241 |
telencephalon | 9.26e-07 | 34 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.